Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
9,783,925
-
Total 13F shares
-
1,772,956
-
Share change
-
+1,772,956
-
Total reported value
-
$12,192,000
-
Price per share
-
$6.87
-
Number of holders
-
12
-
Value change
-
+$12,191,991
-
Number of buys
-
12
Institutional Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) as of Q3 2021
As of 30 Sep 2021,
IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,772,956 shares.
The largest 10 holders included
Capital World Investors, Nantahala Capital Management, LLC, B. Riley Financial, Inc., VANGUARD GROUP INC, Voss Capital, LLC, Tudor Investment Corp Et Al, Rock Creek Group, LP, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., and UBS Group AG.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.